Lung cancer patients live longer with immune therapy
from The New York Times
Odds of survival can greatly improve for people with the most common type of lung cancer if they are given a new drug that activates the immune system along with chemotherapy, a major new study has shown. The findings, medical experts say, should change the way doctors treat lung cancer: Patients with this form of the disease should receive immunotherapy as early as possible.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063